Irrigated Ablation System Evaluation for Atrial Fibrillation (AF)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 324 participants.

Also called NCT01056328

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 324 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01056328
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Canada, South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01056328. Randomized; single masking; primary purpose treatment. Start 2010-02 (registry gives no type); primary completion 2013-01 (actual). Results posted on 2014-05-23.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Irrigated Ablation System Evaluation for Atrial Fibrillation (AF)
Acronym
IRASE-AF
Condition
Paroxysmal Atrial Fibrillation
Intervention (Device)
SJM Irrigated Cardiac Ablation System
Intervention (Device)
FDA approved Open Irrigated RF Ablation System
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct01056328
Content hash
818d5cb6c88569d6f74eed52c9305ce0a4426f064069733cc89db534e8e40987